Innovating & improved solutions in infectious diseases

From microbe to One Health

Our fields

Human health

Human Health

Tacle infectious
diseases

Animal health

Animal Health

Reduce use
of antibiotics

Microbes and environment

Microbes &
Environment

Control microbes
proliferation /
dissemination

Nutraceuticals

Nutraceuticals

Role of gut
microbiota

About Vibiosphen

About
Vibiosphen

One Health paradigm promotes a global effort to achieve the best solutions for human and animal health considering the environment.

Our partners

Latest news about Vibiosphen

Microbiome Movement Drug Development Europe

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Microbiome Movement Drug Development Europe

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Human - Animal One Health: At the Confluence of human & veterinary public health

Integrating a One Health approach in the decision-making process is key for anticipating and tackling crises linked to emerging and reemerging pathogens that affect humans, animals or both